Three simple spectrophotometric methods have been described for the assay of olanzapine in its pure and pharmaceutical formulations. The direct method (A) is based on the drug oxidation with excess of N-bromosuccinimide in acidic medium and the two indirect methods (B and C) are based on the oxidation of the drug with excess of Nbromosuccinimide and cerium(IV)sulfate, followed by the reaction of the unconsumed oxidants with celestine blue. The calibration graphs were linear over the range 10 -120 μg mL -1 (method A), 0.5 -6.0 μg mL -1 (method B) and 0.6 -3.0 μg mL -1 (method C). After validation, the proposed methods were successfully applied to assay of olanzapine in its commercial tablets with mean percentage recoveries of 101.23 ± 0.10, 96 ± 0.10 and 94 ± 0.04%. The mechanism of olanzapine oxidation with N-bromosuccinimide was also proposed.
Introduction
Olanzapine (2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno- [2,3b] [1, 5] benzodiazepine, (Fig. 1) is the most commonly prescribed second-generation neurloteptic for the treatment of psychiatric patients suffering from schizophrenia. Since its introduction in a therapy of psychiatric disorders in 1997, the need for reliable, sensitive and fast methods for its analysis in bulk samples and pharmaceutical preparations is obvious. Several methods have been already reported for the determination of olanzapine (OLA), including hyphenated techniques: HPLC-MS, 1,2 HPLC-UV, [3] [4] [5] [6] [7] [8] [9] GC-MS 10 and electrochemical. 6 There are not many spectrophotometric methods to determine OLA, based on its reaction of oxidation. 11 Therefore it was considered worthwhile to develop new spectrophotometric methods, using N-bromosuccinimide and cerium(IV) sulfate, which have been found to be satisfactory for the assay of OLA in its pure and pharmaceutical formulations.
N-Bromosuccinimide, due to its strong oxidation properties, has been extensively employed as a reagent in the analytical investigations of many organic compounds: phenothiazine derivatives, 12 nitrofurazone, 13 ranitidine, 14 verapamil 15 and prazosin hydrochlorides, 16 tertiary amines and ammonium salts 17 and some catecholamine derivatives. 18 The reaction of oxidation of olanzapine with NBS showed that the investigated drug is easily oxidized with NBS in acidic medium, giving the purple product of oxidation (λ = 532 nm). The optimum conditions (acidity, excess of NBS in respect to OLA, order of reagent addition, time of absorbance measurement) were established before the application of the method to the analysis of the drug in its pure and pharmaceutical preparation. Because the colored product of oxidation of OLA is not stable (it exists for about 360 s) and the absorbance measurements had to be done in the same accurate time, it was necessary to develop new indirect methods of OLA determination. For this aim, the NBS and Ce(SO4)2 were employed in the presence of celestine blue, CB
(1-amino carbonyl-7-diethylamino-3,4-dihydroxy-5-phenoxazinum chloride), which belongs to the group of oxazine dyes and is well known for its high absorptivity. 12 The reaction of celestine blue with an excess of NBS or cerium(IV)sulfate causes the decrease in the intensity of its color.
A great number of organic compounds have been spectrophotometrically determined using excess NBS as oxidant in the presence of celestine blue: propranolol and tetracycline hydrochlorides, 19 omeprazole, 20 azathioprine 12 and astemizole. 21 Cerium(IV)sulfate was earlier used by one of the authors 11 in a direct flow-injection method of olanzapine determination. We decided to check if the indirect spectrophotometric method in system OLA/Ce(IV)/CB will cause a higher sensitivity and increase any other analytical parameters. Our literature review did not find any studies of reaction of excess Ce(IV) ion with celestine blue.
Reagents and chemicals
Standard stock solutions of olanzapine (400 and 200 μg mL -1 ) were prepared from a commercial product Zyprexa (Eli Lilly, Basingstoke, England) by dissolving 40 mg or 20 mg of active substance in 1.0 × 10 -2 mol L -1 H2SO4. The stock solutions were kept in amber-colored bottles and stored at 5˚C until analysis. Working solutions were prepared freshly every day before each analysis by diluting the standard solutions with double distilled water.
Working solutions (1.0 × 10 -2 mol L -1 and 1.2 × 10 -3 mol L -1 ) of N-bromosuccinimide (Schuchardt, München, Germany) were prepared directly before analysis by dissolving an appropriate amount of oxidant in 100 mL of double distilled water.
A working solution (1.0 × 10 -3 mol L -1 ) of Ce(SO4)2·4H2O (VEB Laborchemie Apolda, Germany) was prepared by dissolving an appropriate amount of oxidant in 0.5 mol L -1
H2SO4.
Working solutions of H2SO4, H3PO4, HCl and CH3COOH (P.O.Ch., Gliwice, Poland) were prepared by successive dilutions of appropriate volumes of concentrated acids in double distilled water.
Procedures Calibration graph of OLA assay by its oxidation with NBS (method A).
Into a series of 10 mL volumetric flasks containing 0.25 -3.0 mL of 400 μg mL -1 OLA, 4.5 mL of the mixture of sulfuric and phosphoric acids (1:1, v/v) was placed. The content of the flasks were diluted with double distilled water to 9.0 mL, followed by the addition of 1.0 mL of 1.0 × 10 -3 mol L -1 NBS. The contents were mixed well and after 30 s the absorbance of the colored product of oxidation was measured at 532 nm against a reagent blank. Calibration graph of OLA assay by its oxidation with NBS in the presence of CB (method B). Into a series of 10 mL volumetric flasks containing 0.025 -0.3 mL of 200 μg mL -1 OLA, 1.0 mL of 5.0 mol L -1 HCl and 1.0 mL 1.2 × 10 -3 mol L -1 NBS were added. Each reaction mixture was allowed to stand for 10 min with occasional shaking. After completion of the oxidation of OLA (complete disappearance of purple color), 0.5 mL of 1.0 × 10 -3 mol L -1 CB was placed to each flask and the total volume was adjusted to 10 mL with double distilled water. The absorbance was measured at 538 nm against double distilled water. A blank experiment was also carried out, omitting the drug.
Calibration graph of OLA assay by its oxidation with cerium(IV) sulfate in the presence of CB (method C).
Into a series of 10 mL volumetric flasks containing 0.3 -2.0 mL of 20 μg mL -1 OLA, 1.5 mL of 5.0 mol L -1 H2SO4 and 1.0 mL 1.0 × 10 -3 mol L -1 Ce(SO4)2 were added. Each reaction mixture was allowed to stand for 35 min with occasional shaking, followed by the addition of 0.5 mL 1.0 × 10 -3 mol L -1 CB. The total volume was adjusted to 10 mL with double distilled water. The absorbance was measured at 538 nm against double distilled water. A blank experiment was also carried out omitting the drug. Procedure for dosage form. At least 5 tablets of Zyprexa VeloTab (Eli Lilly, Deutschland, GmbH) and Zalasta (Krka,
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ANALYTICAL SCIENCES JUNE 2006, VOL. 22 Waiting time after addition of oxidant/min Poland) (each tablet consisted of 10 and 5 mg of active substance, respectively) were weighed, powdered and mixed well. A portion equivalent to 10 and 5 mg was accurately weighed and dissolved in about 50 mL of 1.0 × 10 -2 mol L -1 H2SO4. A mechanical stirrer caused the powder to completely disintegrate and then the solution was filtered. The filtrate was transferred into a 100-mL calibrated flask that was filled to the mark with the same solution of acid. Aliquots of the diluted OLA solution (500 and 250 μg mL -1 ) were used for analysis and treated as described above in procedures A, B or C.
Results and Discussion
It was found that olanzapine reacts with NBS (method A) in acidic medium, forming a purple product of oxidation (λ = 532 nm). Of the various acids tested, H2SO4, H3PO4, HCl and CH3COOH sulfuric and phosphoric acids were the most suitable for the reaction. The influence of a mixture of both acids on the absorbance of the colored product of oxidation was also checked. The maximum and stable absorbance from the colored product of oxidation was achieved in the presence of a mixture of sulfuric-phosphoric acids (1:1, v/v, each 5.0 mol L -1 ). The 8 -14-fold excess of NBS with respect to OLA is necessary to complete the reaction between the studied drug and the oxidant. The product of OLA oxidation with NBS is unstable (Fig. 2) ; therefore, the absorbance measurements had to be performed within 30 s after the last reagent-oxidant was added to the mixture with olanzapine and acids. Under optimal conditions, the standard calibration graph was constructed. Beer's law was obeyed in the range of 10 -120 μg of the drug in mL. The analytical data of the elaborated method and its optimum conditions are summarized in Tables 1 and 2 . The results revealed that the proposed method has good precision (RSD = 0.62%), but its sensitivity is not satisfactory enough.
Some studies of the stoichiometry of the reaction of oxidation of olanzapine with aqua solution of NBS using Job's method of continuous variation and spectrophotometric titration method 22 were carried out. Results showed that olanzapine reacts with Nbromosuccinimide in the molar ratio 1:1. The mechanism of olanzapine oxidation was fixed from UV-VIS spectra (Fig. 3) of the unoxidized form of the drug and its oxidized form directly and within 15 min after N-bromosuccinimide addition. The unoxidized olanzapine exhibits one characteristic absorption band at 260 nm; however, its oxidized form directly and after NBS addition exhibits three absorption bands in the UV region at 225, 270 and 340 nm and two absorption bands in the VIS region at 425 and 532 nm.
In the absorption spectrum recorded within 15 min after NBS addition, the bands in the VIS region disappeared. In the UV region, a hypsochromic shift of 5 nm from 225 to 230 and hyperchromicity at 270 and 340 nm were observed. The presence of these three shifts at 230, 270 and 340 nm for oxidized olanzapine is characteristic for sulfones of many pharmaceutical forms. 23 Based on the spectra investigations and literature reports, 24 it can be concluded that the drug is oxidized with NBS through Satom in its thiophene structure in two steps involving two electrons. In the first step, the unstable colored radical cation is formed, followed by its reduction to colorless sulfoxide. With the aim of determining olanzapine S-oxide product, the sensitive color reaction of Wolski 25 with acetyl chloride in the presence of nitrite ions was used. This reaction is used for quantitative sulfoxide determination.
It was found that olanzapine S-oxide reacts with acetyl chloride with the formation of yellow compound. The sensitivity of the above reaction increased by using UV light. Therefore, thin layer chromatography on TLC plates precoated with silica gel (Merck, Darmstadt, Germany) was performed. The sulfoxide solution of olanzapine spotted on the TLC plate was sprayed with acetyl chloride solution. The yellow spot that appeared was developed under UV light. The mechanism of OLA oxidation is shown in Scheme 1.
Due to the low stability of the colored product of OLA oxidation with NBS and the low sensitivity, it was necessary to carry out further studies to elaborate the indirect spectrophotometric method with celestine blue. It was found that excess of oxidant (NBS) added to olanzapine reacts further with an excess of celestine blue (method B). This method involved two steps: oxidation of drug by NBS and an estimation of the unconsumed NBS with a known excess of celestine blue (second step), where we can observe the decreasing intensity of the dye (the reaction product of CB with NBS is colorless). The course of the investigated reactions is shown in Scheme 2. The influences of the acidity, the excess of the oxidant in respect to OLA and CB and the concentration of celestine blue on the course of both reactions have been checked. Optimization experiments revealed that, in the concentration range of 0.2 -1.8 mol L -1 of hydrochloride acid, the maximum and stable absorbance was achieved. Further investigations were done in 0.5 mol L -1 medium of HCl. The 1 -6-fold excess of oxidant in respect to drug and dye was fixed to assure the completed reaction of oxidation of olanzapine, and also amount of unreacted NBS was enough to oxidize of celestine blue. Finally, for further studies, the 4-fold excess of NBS was used. Testing the influence of concentration of CB on its absorbance showed its linear dependence in the concentration range 7.0 × 10 -6 -1.0 × 10 -4 mol L -1 (R = 0.9999). Hence, 5.0 × 10 -5 mol L -1 of CB was selected for further work. The effects of the waiting period, when the dye was added to the mixture of the drug with NBS in respect to minimum blank, and to the reproducibility and stability of the final color were ascertained. It was found the celestine blue can be added after 10 min, since the NBS was inserted in the first step.
The dependence between the absorbance of the unreacted celestine blue and the concentration of olanzapine is shown in Fig. 4 . There are seven absorption spectra: A is the reagent blank, which contained the optimum concentration of the dye (5.0 × 10 -5 mol L -1 ), B -G are the spectra of the mixture of increased amount of olanzapine (from 2 to 6 μg mL -1 ), 0.5 mol L -1 HCl, 1.12 × 10 -4 mol L -1 NBS and 5.0 × 10 -5 mol L -1 CB. On the ground of this linearity dependence, a new indirect spectrophotometric method of olanzapine determination was elaborated. In the optimal conditions, Beer's law was obeyed in the range of 0.5 -6.0 μg mL -1 .
Similar investigations were performed leading the reaction of oxidation of OLA with cerium(IV)sulfate in the presence of celestine blue (method C). On the ground of optimum conditions, the new indirect spectrophotometric method for olanzapine determination, in the range of 0.6 -3.0 μg mL -1 , was elaborated.
Analytical data and optimum conditions for both B and C methods are given in Tables 1 and 2 , respectively. Both B and C methods are marked by good precision (RSD = 1.63% and 2.83%) and sensitivity.
The effects of a wide range of excipients and other additives usually present in the pharmaceutical formulations of olanzapine (starch, lactose, sucrose, glucose) were investigated in the assay (methods A -C) of the drug. A level of interference was considered to be acceptable if the error was not greater than ±5% in the absorbance of the colored product of OLA oxidation (method A) or absorbance of the dye (methods B, C). None of these excipients interfered in the assay. It can be concluded that the elaborated methods are marked by good selectivity.
To confirm the applicability of the proposed procedures, we determined olanzapine in some commercial products: Zyprexa VeloTab ® (Eli Lilly, Deutschland, GmbH) and Zalasta ® (Krka, Poland), which contain 10 mg and 5 mg of bioactive compound. The results obtained by the proposed procedures for dosage form showed that three elaborated A, B and C methods can be applied for the olanzapine determination in tablets. The error of the assay is not greater than 3.7% in respect to nominal content (Table 3) .
Additionally, recovery studies were also carried out to check the accuracy of the proposed procedures. The investigations were carried out employing the standard addition method. For this aim, the model mixtures were prepared, containing known amounts of olanzapine in pharmaceutical preparations Zyprexa VeloTab (method A) and Zalasta (methods B and C) spiked with known amounts of standard olanzapine. The recovery of olanzapine was calculated by comparing the results obtained using the proposed methods before and after the addition of standard solution. The results are given in Table 4 .
Conclusions
The presented methods have been validated and successfully used for the determination of olanzapine in its pure form and in pharmaceutical preparations, with good accuracy (94.0 -101.23%). The studies performed showed that the three elaborated methods are marked by good precision with the relative standard deviation in the range of 0.62 -2.83%. Both indirect methods, in which the N-bromosuccinimide and cerium(IV)sulfate are used in the presence of celestine blue for the oxidation of olanzapine, are more sensitive, compared to the direct oxidative method with N-bromosuccinimide. The proposed procedures offer the advantages of selectivity (there is no interference of reagents) and simplicity and can be used for 832 ANALYTICAL SCIENCES JUNE 2006, VOL. 22 Table 3 routine assay of OLA in its dosage form.
